These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19855172)
21. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site. Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918 [TBL] [Abstract][Full Text] [Related]
22. Expression and clinical implications of P53, P63, and P73 protein in malignant tumor of the parotid gland. Yong M; Yang L; Suyila Q; Han W; Yuan H; Zhao C; Su X Turk J Med Sci; 2014; 44(5):875-82. PubMed ID: 25539561 [TBL] [Abstract][Full Text] [Related]
23. From p63 to p53 across p73. Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031 [TBL] [Abstract][Full Text] [Related]
24. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671 [TBL] [Abstract][Full Text] [Related]
25. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. Boominathan L PLoS One; 2010 May; 5(5):e10615. PubMed ID: 20485546 [TBL] [Abstract][Full Text] [Related]
26. Differential regulation of vitamin D receptor (VDR) by the p53 Family: p73-dependent induction of VDR upon DNA damage. Kommagani R; Payal V; Kadakia MP J Biol Chem; 2007 Oct; 282(41):29847-54. PubMed ID: 17716971 [TBL] [Abstract][Full Text] [Related]
27. Expression of the p53 family of proteins in central and peripheral human corneal endothelial cells. Paull AC; Whikehart DR Mol Vis; 2005 May; 11():328-34. PubMed ID: 15889017 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139 [TBL] [Abstract][Full Text] [Related]
29. Alterations of p63 and p73 in human cancers. Inoue K; Fry EA Subcell Biochem; 2014; 85():17-40. PubMed ID: 25201187 [TBL] [Abstract][Full Text] [Related]
30. Differential regulation of p63 and p73 expression. Waltermann A; Kartasheva NN; Dobbelstein M Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917 [TBL] [Abstract][Full Text] [Related]
31. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values. Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743 [TBL] [Abstract][Full Text] [Related]
32. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73. Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494 [TBL] [Abstract][Full Text] [Related]
33. p63 and p73 in human cancer: defining the network. Deyoung MP; Ellisen LW Oncogene; 2007 Aug; 26(36):5169-83. PubMed ID: 17334395 [TBL] [Abstract][Full Text] [Related]
34. Genome-wide mapping indicates that p73 and p63 co-occupy target sites and have similar dna-binding profiles in vivo. Yang A; Zhu Z; Kettenbach A; Kapranov P; McKeon F; Gingeras TR; Struhl K PLoS One; 2010 Jul; 5(7):e11572. PubMed ID: 20644729 [TBL] [Abstract][Full Text] [Related]
35. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro. Mondal N; Parvin JD Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087 [TBL] [Abstract][Full Text] [Related]
36. p73 and p63 regulate the expression of fibroblast growth factor receptor 3. Sayan AE; D'Angelo B; Sayan BS; Tucci P; Cimini A; Cerù MP; Knight RA; Melino G Biochem Biophys Res Commun; 2010 Apr; 394(3):824-8. PubMed ID: 20298673 [TBL] [Abstract][Full Text] [Related]
37. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73. Venkatanarayan A; Raulji P; Norton W; Flores ER Cell Cycle; 2016; 15(2):164-71. PubMed ID: 26652033 [TBL] [Abstract][Full Text] [Related]
38. Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? Li Y; Prives C Oncogene; 2007 Apr; 26(15):2220-5. PubMed ID: 17401431 [TBL] [Abstract][Full Text] [Related]
39. Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 family. Xu Y; Chen X J Biol Chem; 2006 Sep; 281(36):26702-13. PubMed ID: 16831876 [TBL] [Abstract][Full Text] [Related]
40. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. Dietz S; Rother K; Bamberger C; Schmale H; Mössner J; Engeland K FEBS Lett; 2002 Aug; 525(1-3):93-9. PubMed ID: 12163168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]